Search

Your search keyword '"Cucherat, M."' showing total 294 results

Search Constraints

Start Over You searched for: Author "Cucherat, M." Remove constraint Author: "Cucherat, M."
294 results on '"Cucherat, M."'

Search Results

251. Beta-blocker treatment in heart failure.

252. [Chaos theory in medicine].

253. [Antihypertensive therapy and improved life expectancy without cerebrovascular accident or coronary artery disease].

254. Optimal duration of anticoagulant therapy after an episode of venous thromboembolism.

255. Comparison of bioprosthesis and mechanical valves, a meta-analysis of randomised clinical trials.

257. [Clinical benefits of cholesterol lowering treatments. Meta-analysis of randomized therapeutic trials].

258. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials.

259. [The results of a single clinical trial-is it sufficient information?].

260. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group.

261. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.

262. Trial summary software.

263. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials.

264. [Outline of the problem of indices of therapeutic efficacy. 4. Expression of efficacy when the underlying illness is incurable. Study Group for the Indices of Efficacy].

265. Implication of evidence-based medicine in prescription guidelines taught to French medical students: current status in the cardiovascular field.

266. [The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].

267. Severe morbidity after coronary artery surgery: development and validation of a simple predictive clinical score.

268. Identification of responders to a therapy: an example of validation of a predictive model.

269. [The problem of therapeutic efficacy indices. 2. Description of the indices].

270. [The problem of therapeutic efficacy indices. 1. Elements of the problem].

271. [Local control of the primary tumor. Necessary step in control of cancer].

272. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

273. [Identification and prediction of responders to a therapy. A model and its preliminary application to hypertension].

274. What target for guidelines: uniformed or tailored?

275. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis.

276. A meta-analysis of the effects of cognitive therapy in depressed patients.

277. Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis.

278. Revisiting the effect compartment through timing errors in drug administration.

279. A mathematical model for the determination of the optimum value of the treatment threshold for a continuous risk factor.

280. The meta-analysis of diagnostic test studies.

281. EasyMA: a program for the meta-analysis of clinical trials.

282. Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prévention Secondaire de l'Infarctus.

283. Standardization of terminology in meta-analysis: a proposal for working definitions.

284. [Nifedipine and coronary insufficiency: reasons for controversy].

285. [Role of meta-analysis in the definition of target population in therapy].

286. [Effect models and meta-analysis].

287. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis.

288. [Meta-analysis of therapeutic trials: applications in psychiatry].

289. [Integratable message: central problem of communication for therapeutic information].

290. Use of a spreadsheet program for circadian analysis of biological/physiological data.

291. Critical reading of the meta-analysis of clinical trials.

292. [Introduction to meta-analytic methodology].

293. [Economic evaluation of treatments of cardiac insufficiency].

294. [Meta-analysis of therapeutic trials of primary prevention in ischemic cardiopathies by hypocholesteremic treatment].

Catalog

Books, media, physical & digital resources